Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dilorom M, Djalilova"'
Publikováno v:
Sleep Medicine Clinics. 13:395-417
Sleep deficiency is common and distressing for women with breast cancer throughout the care continuum. This article describes the scope and quality of evidence related to exercise interventions to improve sleep in women with breast cancer. Fifteen st
Publikováno v:
Public Health Nursing.
Cancer-related fatigue (CRF) is an important public health issue that involves millions of community-dwelling cancer survivors. CRF is the most debilitating patient reported symptom related to cancer therapies and exacts a significant economic and so
Autor:
Kevin A. Kupzyk, Adam J. Case, Paula Schulz, Ann M. Berger, Alyson Ross, Dilorom M. Djalilova
Background: Many chronic conditions, including heart disease, cancer, and rheumatoid arthritis, are associated with underlying chronic inflammatory processes. Literature reviews have analyzed a variety of integrative therapies and their relationships
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d37030a56dc67f6bf560aac560bce367
https://europepmc.org/articles/PMC6700894/
https://europepmc.org/articles/PMC6700894/
Publikováno v:
Sleep medicine clinics. 13(3)
Sleep deficiency is common and distressing for women with breast cancer throughout the care continuum. This article describes the scope and quality of evidence related to exercise interventions to improve sleep in women with breast cancer. Fifteen st
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 27(4)
SIGNIFICANCE: Poor sleep quality is a common and persistent problem reported by women with breast cancer (BC). Empirical evidence identifies many risk factors for self-reported sleep deficiency but inconsistencies limit translation to practice. PURPO
Autor:
Ann M. Berger, Dilorom M. Djalilova, Russell J. Buzalko, Bret J. Gardner, Julie L. Otte, Kevin A. Kupzyk
Publikováno v:
Acta oncologica (Stockholm, Sweden). 56(12)
There is renewed interest in identifying breast cancer patients' participation in decision-making about adjuvant chemotherapy. There is a gap in the literature regarding the impact of these decisions on quality of life (QOL) and quality of care (QOC)